Legis Daily

Securing Innovation and Research from Adversaries Act

USA119th CongressS-4525| Senate 
| Updated: 5/14/2026
Jim Banks

Jim Banks

Republican Senator

Indiana

Homeland Security and Governmental Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill establishes a prohibition on the use of federally funded research awards for collaborations with certain foreign entities or individuals. Specifically, no federal funds can be used by an individual or entity receiving a research award to engage in any research collaboration with an entity listed on a United States Government restricted entity list or an individual associated with such an entity. This measure is designed to safeguard national security and protect American innovation from potential adversaries. The legislation broadly defines "research collaboration" to include joint research activities, co-authorship, data sharing, personnel exchanges, and joint laboratories. The "United States Government restricted entity list" encompasses a wide array of existing lists maintained by various federal agencies, such as the Commerce Department's Entity List, the Treasury Department's SDN list, and lists related to Chinese military companies or forced labor. This comprehensive scope ensures that collaborations with entities deemed a risk to U.S. interests are restricted. To ensure consistent implementation, the Director of the Office of Science and Technology Policy, in consultation with relevant federal research agencies, is directed to issue government-wide guidance. Federal agencies retain a limited waiver authority , allowing them to permit collaborations on a case-by-case basis if deemed necessary for U.S. national security interests or for essential scientific or public health purposes that cannot otherwise be achieved. Any such waiver must be reported to Congress within 30 days, detailing the justification and any mitigation measures taken.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 14, 2026
Introduced in Senate
May 14, 2026
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
May 19, 2026

Latest Companion Bill Action

HR 119-8901
Introduced in House
  • May 14, 2026
    Introduced in Senate


  • May 14, 2026
    Read twice and referred to the Committee on Homeland Security and Governmental Affairs.


  • May 19, 2026

    Latest Companion Bill Action

    HR 119-8901
    Introduced in House

International Affairs

Securing Innovation and Research from Adversaries Act

USA119th CongressS-4525| Senate 
| Updated: 5/14/2026
This bill establishes a prohibition on the use of federally funded research awards for collaborations with certain foreign entities or individuals. Specifically, no federal funds can be used by an individual or entity receiving a research award to engage in any research collaboration with an entity listed on a United States Government restricted entity list or an individual associated with such an entity. This measure is designed to safeguard national security and protect American innovation from potential adversaries. The legislation broadly defines "research collaboration" to include joint research activities, co-authorship, data sharing, personnel exchanges, and joint laboratories. The "United States Government restricted entity list" encompasses a wide array of existing lists maintained by various federal agencies, such as the Commerce Department's Entity List, the Treasury Department's SDN list, and lists related to Chinese military companies or forced labor. This comprehensive scope ensures that collaborations with entities deemed a risk to U.S. interests are restricted. To ensure consistent implementation, the Director of the Office of Science and Technology Policy, in consultation with relevant federal research agencies, is directed to issue government-wide guidance. Federal agencies retain a limited waiver authority , allowing them to permit collaborations on a case-by-case basis if deemed necessary for U.S. national security interests or for essential scientific or public health purposes that cannot otherwise be achieved. Any such waiver must be reported to Congress within 30 days, detailing the justification and any mitigation measures taken.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 14, 2026
Introduced in Senate
May 14, 2026
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
May 19, 2026

Latest Companion Bill Action

HR 119-8901
Introduced in House
  • May 14, 2026
    Introduced in Senate


  • May 14, 2026
    Read twice and referred to the Committee on Homeland Security and Governmental Affairs.


  • May 19, 2026

    Latest Companion Bill Action

    HR 119-8901
    Introduced in House
Jim Banks

Jim Banks

Republican Senator

Indiana

Homeland Security and Governmental Affairs Committee

International Affairs

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted